首頁 › 心臟衰竭 › 明尼蘇達 › Minneapolis
Minneapolis, MN 的 心臟衰竭 臨床試驗
21 項針對 心臟衰竭 的研究正在 Minneapolis（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
ELEVATE-HFpEF Clinical Study
招募中
- M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
招募中3 期
- Minneapolis VA Health Care System, Minneapolis
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
招募中3 期
- Minneapolis VA Health Care System, Minneapolis
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
招募中3 期
- University of Minnesota, Minneapolis
Alleviant ALLAY-HFrEF Study
招募中
- Minneapolis Heart Institute Foundation, Minneapolis
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
招募中3 期
- Research Site, Minneapolis
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
招募中3 期
- Minneapolis, MN Investigative Site 10091, Minneapolis
- Minneapolis, MN Investigative Site 10035, Minneapolis
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
招募中3 期
- Minneapolis, MN Investigative Site CON-10035, Minneapolis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
招募中
- Abbott Northwestern Hospital, Minneapolis
- University of Minnesota, Minneapolis
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
招募中觀察性研究
- Minneapolis, Minneapolis
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
招募中觀察性研究
- Minneapolis Heart Institute Foundation, Minneapolis
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
招募中3 期
- Tenax Investigational Site, Minneapolis
Alleviant ALLAY-HF Study
招募中
- Minneapolis Heart Institute Foundation, Minneapolis
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
招募中
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Assessment of CCM in HF With Higher Ejection Fraction
招募中
- Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
招募中3 期
- Minneapolis, MN Investigative Site FIN-10035, Minneapolis
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
招募中
- University of Minnesota, Minneapolis
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
招募中
- Minneapolis Heart Institute, Minneapolis
CCM OPEN HF Registry
招募中觀察性研究
- Minneapolis Heart Institute Research Foundation, Minneapolis
Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance
招募中觀察性研究
- Minneapolis Heart Institute Foundation, Minneapolis
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
招募中觀察性研究
- Minneapolis Heart Institute Foundation/ Allina Health, Minneapolis
其他城市的 心臟衰竭 試驗
- New York City, NY51 項研究
- Boston, MA44 項研究
- Dallas, TX42 項研究
- Houston, TX36 項研究
- Cleveland, OH33 項研究
- Chicago, IL31 項研究
- Philadelphia, PA31 項研究
- San Francisco, CA29 項研究
- Durham, NC26 項研究
- St. Louis, MO26 項研究
- Atlanta, GA25 項研究
- Kansas City, MO25 項研究
Minneapolis 的其他研究
- 非小細胞肺癌27 項研究
- 乳癌27 項研究
- 卵巢癌24 項研究
- 前列腺癌23 項研究
- 癌症（所有類型）22 項研究
- 急性髓系白血病20 項研究
- 肺癌20 項研究
- 大腸直腸癌19 項研究
- 子宮內膜癌18 項研究
- 帕金森氏症17 項研究
- 心血管疾病15 項研究
- 冠狀動脈疾病13 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。